Methylation profiles of IL33 and CCL26 in bronchial epithelial cells are associated with asthma

Epigenomics. 2018 Dec;10(12):1555-1568. doi: 10.2217/epi-2018-0044. Epub 2018 Nov 23.

Abstract

Aim: This study aimed to characterize DNA methylation (DNA-me) in promoter region of IL33, IL1RL1 and CCL26 in asthma and their impacts on transcriptional activity in bronchial epithelial cells (BECs).

Patients & methods: We performed bis-pyrosequencing, quantitative real-time PCR and sequencing in BECs from ten asthmatic and ten control individuals.

Results: We detected lower DNA-me levels of IL33 and CCL26 in asthmatic than control BECs. No correlation was found between methylation and expression levels. Interestingly, carriers of a mutative allele in a haplotype within the promoter of IL33 had a lower IL33 DNA-me level and CCL26 gene expression correlated with eosinophil count.

Conclusion: These findings highlight the importance of investigating both epigenetic and genetic mechanisms in understanding the epithelial immune response in asthma.

Keywords: DNA methylation; bronchial epithelial cell; eosinophil; gene expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alleles
  • Asthma / genetics*
  • Asthma / immunology
  • Chemokine CCL26 / genetics*
  • DNA Methylation*
  • Eosinophils / immunology
  • Epigenomics
  • Epithelial Cells / immunology
  • Female
  • Gene Expression Regulation / genetics*
  • Haplotypes
  • Humans
  • Interleukin-1 Receptor-Like 1 Protein / genetics*
  • Interleukin-33 / genetics*
  • Lung / immunology
  • Male
  • Middle Aged
  • Mutation
  • Promoter Regions, Genetic / genetics
  • Young Adult

Substances

  • CCL26 protein, human
  • Chemokine CCL26
  • IL1RL1 protein, human
  • IL33 protein, human
  • Interleukin-1 Receptor-Like 1 Protein
  • Interleukin-33

Grants and funding